Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Mills

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade TherapiesShiyou Wei, Kuang Du, Hongbin Lan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapyWoo-Young Kim, Dong Jo Chang, Bryan Hennessy, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2022
IMP1/IGF2BP1 in human colorectal cancer extracellular vesiclesMadeline Kuhn, Yang Zhang, John Favate, et al.
Nature Genetics|April 4, 2008
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Christopher I Amos, Xifeng Wu, Peter Broderick, et al.
Journal of the American College of Cardiology|December 17, 2021
Early Hospital Discharge Following PCI for Patients With STEMIKrishnaraj S Rathod, Katrina Comer, Oliver Casey-Gillman, et al.
Nature Communications|April 20, 2021
Spatially interacting phosphorylation sites and mutations in cancerKuan-Lin Huang, Adam D Scott, Daniel Cui Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Tae Beom Kim, Bo Peng, et al.
Pharmacological Research|September 24, 2021
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitorsÉrica Aparecida de Oliveira, Jagat Chauhan, Julia Rezende da Silva, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
American Journal of Clinical Pathology|October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencingSinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade TherapiesShiyou Wei, Kuang Du, Hongbin Lan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapyWoo-Young Kim, Dong Jo Chang, Bryan Hennessy, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2022
IMP1/IGF2BP1 in human colorectal cancer extracellular vesiclesMadeline Kuhn, Yang Zhang, John Favate, et al.
Nature Genetics|April 4, 2008
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Christopher I Amos, Xifeng Wu, Peter Broderick, et al.
Journal of the American College of Cardiology|December 17, 2021
Early Hospital Discharge Following PCI for Patients With STEMIKrishnaraj S Rathod, Katrina Comer, Oliver Casey-Gillman, et al.
Nature Communications|April 20, 2021
Spatially interacting phosphorylation sites and mutations in cancerKuan-Lin Huang, Adam D Scott, Daniel Cui Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Tae Beom Kim, Bo Peng, et al.
Pharmacological Research|September 24, 2021
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitorsÉrica Aparecida de Oliveira, Jagat Chauhan, Julia Rezende da Silva, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
American Journal of Clinical Pathology|October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencingSinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
Pageof 7